Printer Friendly

Browse Chronic myeloid leukemia topic

Drug therapy subtopic

Articles

1-30 out of 30 article(s)
Title Author Type Date Words
ALTERED APOPTOTIC PROTEIN EXPRESSIONS CHARACTERIZE THE SURVIVAL OF BCR-ABL-INDEPENDENT DRUG-RESISTANT CHRONIC MYELOID LEUKEMIA CELL LINE. Baykal-Kose, Seda; Yalcin, Pelin Jan 1, 2021 2406
Terns Pharmaceuticals and Hansoh Pharma to develop and commercialise TRN-000632 for treatment of chronic myeloid leukemia in Greater China. Jul 28, 2020 239
Terns Pharmaceuticals and Hansoh Pharma to develop and commercialise TRN-000632 for treatment of chronic myeloid leukemia in Greater China. Jul 28, 2020 235
Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments. Xu, Lianrong; Zhao, Yan; Pan, Fei; Zhu, Mengxia; Yao, Liqin; Liu, Yan; Feng, Jiangfang; Xiong, Jie; Dec 31, 2019 7166
Chronic Myelogenous Leukemia Treatment Market Size, Share, Trends and Future Growth Predictions till. Jun 18, 2019 822
Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method. Kalindemirtas, Ferdane Danisman; Birman, Husniye; Candoken, Eda; Gazioglu, Sema Bilgig; Melikoglu, G Report Mar 1, 2019 5257
An Unprecedented Case of p190 BCR-ABL Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature. Miki, Kosuke; Obara, Naoshi; Makishima, Kenichi; Sakamoto, Tatsuhiro; Kusakabe, Manabu; Kato, Takaya Jan 1, 2018 3012
Nilotinib induced skin rash in chronic myeloid leukemia patients: a case series. Wasekar, Nilesh; Mohite, Aniket B.; Chandrakala, S.; Vinod, P.; Rajesh P.; Shailesh B.; Jijina, Fara Report Mar 1, 2017 1857
Dasatinib-induced chylothorax in chronic myeloid leukemia. Baloch, Zulfiqar Qutrio; Abbas, Shabber Agha; Bhatti, Hammad; Braver, Yvonne; Ali, Sayed K. Clinical report Jan 1, 2017 1922
The Hasford score may predict molecular response in chronic myeloid leukemia patients: A single institution experience. Dybko, Jaroslaw; Jazwiec, Bohena; Haus, Olga; Urbaniak-Kujda, Donata; Kapelko- Slowik, Katarzyna; Wr Report Jan 1, 2016 3059
"Unsustainable" cancer drug prices. Faloon, William Report Apr 1, 2014 4445
Teva Pharmaceutical Industries Ltd wins FDA approval of SYNRIBO for treating people living with chronic or accelerated phase chronic myeloid leukemia. Feb 14, 2014 148
Teva Pharmaceutical Industries Ltd wins FDA approval of SYNRIBO for treating people living with chronic or accelerated phase chronic myeloid leukemia. Feb 14, 2014 144
Current management of chronic myeloid leukemia with tyrosine kinase inhibitors / Kronik Myeloid Losemi Guncel Tedavisinde Tirozin Kinaz Inhibitorleri. Haznedaroglu, Ibrahim C. Report Sep 1, 2013 6697
Gynecomastia in a boy with chronic myeloid leukemia during imatinib therapy / Kronik Miyeloid Losemili Bir Erkek Cocukta, Imatinib Tedavisi Sirasinda Ge1isen Jinekomasti. Tavil, Betul; Kinik, Sibel; Gozen, Ahmet; Olcay, Lale Clinical report Sep 1, 2013 1401
Dasatinib may override F317L BCR-ABL kinase domain mutation in patients with chronic myeloid leukemia / Dasatinib F317L BCR-ABL Mutasyonu Olan Kronik Miyeloid Losemi Hastalarinda Etkili Olabilir. Eskazan, Ahmet Emre; Soysal, Teoman Clinical report Jun 1, 2013 1364
Imatinib mesylate effectiveness in chronic myeloid leukemia with additional cytogenetic abnormalities at diagnosis among Black Africans. Aissata, Tolo Diebkile; Sawadogo, Duni; Nanho, Clotaire; Kouakou, Boidy; Meite, N'dogomo; Emeuraude, Jan 1, 2013 3114
Imatinib may give normal life expectancy to patients with CML. McBride, Deborah Report Jun 1, 2011 329
Novartis Tasigna more effective than Glivec in patients with chronic myeloid leukemia. Dec 9, 2009 307
Drugs offer new hope for patients with CML who are resistant to Imatinib: as seen in the Clinical Journal of Oncology Nursing. Oestreicher, Pamela Jul 1, 2007 1117
Panel endorses dasatinib for imatinib-resistant CML. Tanzola, Melinda Clinical report Jul 1, 2006 1014
Next line of defense: new drugs take on resistant leukemia. Seppa, N. Jun 17, 2006 503
Leukemia drug and diabetes. Foley, Kevin Brief Article May 1, 2005 132
Oral agent shows promise for chronic myeloid leukemia. Jan 15, 2005 398
Imatinib beats interferon for first-line initial CML therapy. (Chronic Myeloid Leukemia). Zoler, Mitchel L. Product/Service Evaluation Feb 1, 2003 808
Interferon: Low or high dose equally effective. (Clinical Rounds: First randomized myeloid leukemia study). DeMott, Kathryn Brief Article Apr 1, 2002 494
Leukemia overpowers drug in two ways. Seppa, N. Brief Article Jun 23, 2001 582
THIS MAN MAY HAVE JUST CURED CANCER. KATAUSKAS, TED Statistical Data Included Jul 1, 2000 1963
Dramatic Results in Trial of New Leukemia Drug. CHENG, GUANG-SHING Feb 1, 2000 590
New Drug Thwarts a Chronic Leukemia. Seppa, N. Brief Article Dec 11, 1999 636

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |